go site A drug that may melt away cancer cells has been approved in Australia for use in patients of a particular type of leukaemia who have not responded to existing therapies.
http://pricescreameries.com/products/other-dairy/heavy-whipping-cream/ The drug, Venetoclax, has been approved by Australia’s Therapeutic Goods Administration (TGA) for some stage four patients of chronic lymphocytic leukaemia.
It works by blocking the action of a protein, known as BCL-2, that enables cancer cells to survive. It will be available to patients who have not responded to standard treatments or have not been able to undergo other therapies, such as chemotherapy. Full Story